English
繁體中文
Melayu
Nederlands
日本語
Italiano
Deutsch
Português
Español
Pусский
Français
العربية
简体中文
Bahasa indonesia
Polski

NEWS DETAIL
Home » News » News » Bioteke Innovative 10-in-1 Respiratory Antigen Rapid Test Kit Is Launched

Bioteke Innovative 10-in-1 Respiratory Antigen Rapid Test Kit Is Launched

Publish Time: 2025-02-08     Origin: Bioteke

PREVIEW

Precision medical diagnosis serves efficient medical treatment.

Urgent need for global respiratory infection prevention and control


At the beginning of 2025, respiratory infection cases surged in the northern hemisphere in winter, and multiple pathogens such as influenza virus, human metapneumovirus, and respiratory syncytial virus were prevalent, resulting in tight medical resources and rising demand for testing. 


The World Health Organization (WHO) called for strengthening routine prevention and rapid diagnosis to cope with seasonal transmission risks. Against this background, our company launched a 10-in-1 rapid antigen test kit for multiple respiratory pathogens, which uses immunochromatography and double antibody sandwich technology to provide efficient and accurate in vitro diagnostic solutions for medical institutions, primary clinics and home users.


PRODUCT HIGHLIGHTS


  • Multiple pathogens covered, one kit for efficient detection

This kit can simultaneously detect 10 respiratory pathogens, including COVID-19, influenza A/B virus, parainfluenza virus (type 1/2/3), respiratory syncytial virus, adenovirus, Mycoplasma pneumoniae, Streptococcus pneumoniae, Human metapneumovirus, covering the main pathogen types currently prevalent in the world. 

Comprehensive screening can be completed with one sampling, significantly improving detection efficiency and reducing the risk of cross-infection.


  • High sensitivity and specificity

Based on immunochromatography and double antibody sandwich method, the sensitivity is more than 98%, the specificity is 100%, and the total coincidence rate is more than 99%

It can accurately distinguish pathogen types, reduce the risk of false positives/false negatives, and meet the needs of screening and diagnosis.


  • Convenience and quick response

As a POCT (point-of-care test) product, it does not require specialized equipment or complex operations. It only requires an oropharyngeal swab specimens and results can be obtained within 15 minutes. 

It is especially suitable for medical institutions to quickly triage patients and develop treatment plans.


  • Strict compliance and international certification

The products comply with CE-IVDD international standards and have passed ISO 13485 quality management system certification to ensure market access compliance.


APPLICATION SCENARIOS

Application scenarios and prevention and control value in the international market


1). Responding to seasonal infection waves

Recent data show that the influenza virus positivity rate in many countries in Europe, America and Asia exceeds 35%, and human metapneumovirus continues to spread among children. This test kit can quickly identify mixed infection cases, provide a basis for precise medication (such as the antiviral drug oseltamivir), and avoid the abuse of antibiotics.


2). Relieve the pressure on medical resources

During the peak period of medical treatment, POCT products can divert screening and testing pressure and reduce patient waiting time. For example, the UK, Japan and other places have experienced a shortage of medical care due to a surge in respiratory cases, and rapid testing has become a key tool for optimizing resource allocation.


3). Support public health monitoring

The test kit is suitable for routine screening in crowded places such as airports and schools, and cooperates with the government's epidemic monitoring network to help detect clustered epidemics early and block the transmission chain.



GLOBAL COLLABORATION


  • Customized registration support

In response to different national regulations, our company provides localized registration documents and technical support to accelerate the product launch process.


  • Supply chain and warehousing optimization

The regular production cycle takes only 7 days. Relying on the global logistics network, the test kit is ensured to be stably transported at 2-30℃, with a shelf life of up to 24 months, which is suitable for tropical, temperate and other climate regions.



CONCLUSION

Work together to build a healthy respiratory defense line


Faced with the complex and ever-changing situation of respiratory infections, rapid and accurate diagnosis is the core link of prevention, control and treatment.


Bioteke 10-in-1 antigen test kit is centered on technological innovation and compliance, providing reliable tools for global users. Medical institutions, distributors and public health departments are welcome to inquire about cooperation to jointly respond to infection challenges and protect human health.


Contact us now to obtain product manuals, clinical data and regional agency policies!


Website: www.bioteke.cn

E-mail: zr@bioteke.cn

Phone/Whatsapp: +86 181 1536 3743

Address: No. 9 Huiming Rd. Huishan District, Wuxi, 214174, China



Compliance Statement: This product is for in vitro diagnostic use only and must comply with the medical device use regulations of various countries. For specific registration information, please refer to the public notice of the local regulatory agency.






Copyright BioTeke Corporation(wuxi) Co.,Ltd  |   苏ICP备18042459号-1